PharmD Info

A forum for Indian Pharmacy Professionals

Free Online Pharmacy Courses from OpenWHO, Uppsala, John Hopkins, Swayam, NPTEL in Pharmacy Practice, Pharmaceutics, Regulatory etc.

Moderator: Admin

Forum rules: General rules are applicable for this forum- Find Here
  • User avatar
#6098
The Pharmacy Council of India (PCI) has taken a significant step forward in pharmaceutical education by introducing a mandatory online course on the Rational Use of Medicines, developed in collaboration with WHO India and THSTI.

Key Highlights

- Free online course available through THSTI's Learning Management System (LMS)
- Accessible via web portal and mobile app
- Mandatory for CEP programs and registration renewal
- Collaborative effort between PCI, WHO India, and THSTI
- Part of broader initiatives to enhance pharmacist skills

Understanding the New E-Learning Initiative

In a groundbreaking move to enhance pharmaceutical practices across India, the Pharmacy Council of India (PCI) has launched a comprehensive e-learning course focusing on the Rational Use of Medicines. This initiative, developed in partnership with the World Health Organization (WHO) India Country Office and the Translational Health Science & Technology Institute (THSTI), represents a significant step toward standardizing and improving pharmaceutical education in India.

How to Access the Course

The course is readily accessible through multiple platforms:

1. Web Portal: Visit https://lms.thsti.in/
2. Mobile App: Available on both Google Play Store and Apple App Store under "THSTI App"

Course Structure and Requirements

The program has been thoughtfully designed to ensure comprehensive learning while maintaining flexibility for working professionals. Participants must:

- Complete all modules sequentially
- Pass the exit assessment
- Receive a completion certificate valid for registration renewal

Additional Skills Development Initiative

In parallel with the e-learning course, PCI has announced a partnership with the Life Sciences Sector Skill Development Council (LSSSDC) under the Pradhan Mantri Kaushal Vikas Yojana (PMKVY 4.0). This program offers:

- 26,500 seats for registered pharmacists
- 30 hours of mandatory training
- Flexible daily training hours (2-8 hours)
- Program orientation and mock assessments
- Official certification upon completion

Impact on Registration Renewal

Both the Rational Use of Medicines course and the LSSSDC certification are now valid for registration renewal under regulation 4.2 of Pharmacy Practice Regulations, 2015. This integration ensures that continuing education remains relevant and practical for working pharmacists.

Why This Matters

The introduction of these programs represents a significant shift in pharmaceutical education in India. By combining WHO guidelines with practical skills development, PCI is ensuring that Indian pharmacists remain at the forefront of global pharmaceutical practices while maintaining high standards of professional competence.

Looking Ahead

These initiatives mark just the beginning of PCI's renewed focus on continuous professional development. The combination of e-learning flexibility with practical skill enhancement provides a robust framework for the future of pharmaceutical education in India.

Get Started Today

Registered pharmacists are encouraged to enroll in these programs immediately. The courses offer a unique opportunity to enhance professional knowledge while fulfilling registration renewal requirements.

*For more information and registration details, visit the official PCI website or contact your State Pharmacy Council.*
Similar Topics
Topics Statistics Last post
mRNA Vaccines: A Game-Changer in Immunotherapy
by Admin    - In: Pharma Talk
0 Replies 
508 Views
by Admin
0 Replies 
579 Views
by Admin
0 Replies 
555 Views
by Swathi Swaroopa B
0 Replies 
380 Views
by Admin
0 Replies 
464 Views
by Admin

Drug-resistant pneumonia is a silent killer, quiet[…]

The Pharmacy Council of India (PCI) has taken a si[…]

The Pharmacy Council of India (PCI) has announced […]

In the evolving landscape of antimicrobial steward[…]

PharmD Info - Highlights